The DOI matches its Crossref record; 110 of the 110 references it cites were found in a registry or an index.
RU486 (MIFEPRISTONE): Mechanisms of Action and Clinical Uses
Abstract
▪ Abstract RU486 (mifepristone) has proved to be a remarkably active antiprogesterone and antiglucocorticosteroid agent in human beings. The mechanism of action involves the intracellular receptors of the antagonized hormones (progesterone and glucocorticosteroids). At the molecular level, the most important features are high binding affinity to the receptor, interaction of the phenylaminodimethyl group in the 11β-position with a specific region of the receptor binding pocket, and RU486-induced transconformation differences in the ligand-binding domain. These particularities have consequences at different steps of the receptor function as compared with agonists. However, the reasoning cannot be limited to the RU486-receptor interaction, and, for instance, there is the possibility of a switch from antagonistic property to agonist activity, depending on the intervention of other signaling pathways. It would be desirable to have derivatives with only one of the two antagonistic properties (antiprogestin, antiglucocorticosteroid) in spite of similarities between steroid structures, receptors involved, and responsive machineries in target cells. Clinically, the RU486-plus-prostaglandin method is ready to be used on a large scale and is close to being as convenient and safe as any medical method of abortion may be. The early use of RU486 as a contragestive as soon as a woman fears a pregnancy she does not want will help to defuse the abortion issue. Research should now be conducted to define an efficient and convenient contraceptive method with RU486 or other antiprogestins. The usefulness of RU486 for obstetric indications, including facilitation of difficult delivery, has to be assessed rapidly. Gynecologic trials, particularly in leiomyomata, should also be systematically continued. The very preliminary results obtained with tumors, including breast cancers, indicate that further studies are necessary.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Steroid and Thyroid Hormone Receptor Superfamily
Evans, R. M. (1988) · Science · doi:10.1126/science.3283939 · Cited by 7,439
MOLECULAR MECHANISMS OF ACTION OF STEROID/THYROID RECEPTOR SUPERFAMILY MEMBERS
Tsai, M.-J., & O'Malley, B. W. (1994) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.63.070194.002315 · Cited by 2,932
Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-α
Bourguet, W., Ruff, M., Chambon, P., Gronemeyer, H., & Moras, D. (1995) · Nature · doi:10.1038/375377a0 · Cited by 1,177
Steroid Receptor Family: Structure and Functions
CARSON-JURICA, M. A., SCHRADER, W. T., & O'MALLEY, B. W. (1990) · Endocrine Reviews · doi:10.1210/edrv-11-2-201 · Cited by 811
Vegeto, E., Shahbaz, M. M., Wen, D. X., Goldman, M. E., O'Malley, B. W., & McDonnell, D. P. (1993) · Molecular Endocrinology · doi:10.1210/mend.7.10.8264658 · Cited by 760
Contragestion and Other Clinical Applications of RU 486, an Antiprogesterone at the Receptor
Baulieu, E.-E. (1989) · Science · doi:10.1126/science.2781282 · Cited by 483
Treatment of unresectable meningiomas with the antiprogesterone agent mifepristone
Grunberg, S. M., Weiss, M. H., Spitz, I. M., Ahmadi, J., Sadun, A., Russell, C. A., Lucci, L., & Stevenson, L. L. (1991) · Journal of Neurosurgery · doi:10.3171/jns.1991.74.6.0861 · Cited by 379
TRANSCRIPTION ACTIVATION BY ESTROGEN AND PROGESTERONE RECEPTORS
Gronemeyer, H. (1991) · Annual Review of Genetics · doi:10.1146/annurev.ge.25.120191.000513 · Cited by 378
Vegeto, E., Allan, G. F., Schrader, W. T., Tsai, M.-J., McDonnell, D. P., & O'Malley, B. W. (1992) · Cell · doi:10.1016/0092-8674(92)90234-4 · Cited by 377
Allan, G. F., Leng, X., Tsai, S. Y., Weigel, N. L., Edwards, D. P., Tsai, M. J., & O'Malley, B. W. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)41805-4 · Cited by 355
Agonistic and antagonistic activities of RU486 on the functions of the human progesterone receptor.
Meyer, M. E., Pornon, A., Ji, J. W., Bocquel, M. T., Chambon, P., & Gronemeyer, H. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07613.x · Cited by 328
Successful Treatment of Cushing’s Syndrome with the Glucocorticoid Antagonist RU 486*
NIEMAN, L. K., CHROUSOS, G. P., KELLNER, C., SPITZ, I. M., NISULA, B. C., CUTLER, G. B., MERRIAM, G. R., BARDIN, C. W., & LORIAUX, D. L. (1985) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-61-3-536 · Cited by 317
Becker, P. B., Gloss, B., Schmid, W., Strähle, U., & Schütz, G. (1986) · Nature · doi:10.1038/324686a0 · Cited by 313
Glasier, A., Thong, K. J., Dewar, M., Mackie, M., & Baird, D. T. (1992) · New England Journal of Medicine · doi:10.1056/nejm199210083271501 · Cited by 310
BALDI, E., CASANO, R., FALSETTI, C., KRAUSZ, C., MAGGI, M., & FORTI, G. (1991) · Journal of Andrology · doi:10.1002/j.1939-4640.1991.tb01610.x · Cited by 309
Superfamily of steroid nuclear receptors: positive and negative regulators of gene expression
Wahli, W., & Martinez, E. (1991) · The FASEB Journal · doi:10.1096/fasebj.5.9.1860615 · Cited by 294
Cell surface-binding sites for progesterone mediate calcium uptake in human sperm.
Blackmore, P. F., Neulen, J., Lattanzio, F., & Beebe, S. J. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)55113-9 · Cited by 285
Uterine contractility and induction of abortion in early pregnancy by misoprostol and mifepristone
Norman, J. E., Thong, K. J., & Baird, D. T. (1991) · The Lancet · doi:10.1016/0140-6736(91)92102-8 · Cited by 280
Regression of uterine leiomyomata in response to the antiprogesterone RU 486.
Murphy, A. A., Kettel, L. M., Morales, A. J., Roberts, V. J., & Yen, S. S. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.76.2.8432797 · Cited by 247
Termination of Early Pregnancy by the Progesterone Antagonist RU 486 (Mifepristone)
Couzinet, B., Strat, N. L., Ulmann, A., Baulieu, E. E., & Schaison, G. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612183152501 · Cited by 236
The New Steroid Analog RU 486 Inhibits Glucocorticoid Action in Man
BERTAGNA, X., BERTAGNA, C., LUTON, J.-P., HUSSON, J.-M., & GIRARD, F. (1984) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-59-1-25 · Cited by 235
Down-regulation and Phosphorylation of Glucocorticoid Receptors in Cultured Cells
Hoeck, W., Rusconi, S., & Groner, B. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)71692-x · Cited by 223
HORWITZ, K. B. (1992) · Endocrine Reviews · doi:10.1210/edrv-13-2-146 · Cited by 221
Mifepristone (RU 486) -- A Modulator of Progestin and Glucocorticoid Action
Wood, A. J. J., Spitz, I. M., & Bardin, C. W. (1993) · New England Journal of Medicine · doi:10.1056/nejm199308053290607 · Cited by 221
Treatment of endometriosis with the antiprogesterone mifepristone (RU486)
Michael Kettel, L., Murphy, A. A., Morales, A. J., Ulmann, A., Baulieu, E. E., & Yen, S. S. C. (1996) · Fertility and Sterility · doi:10.1016/s0015-0282(16)58022-4 · Cited by 216
Self-citationComparison of Yuzpe regimen, danazol, and mifepristone (RU486) in oral postcoital contraception.
Webb, A. M., Russell, J., & Elstein, M. (1992) · BMJ · doi:10.1136/bmj.305.6859.927 · Cited by 216
Gaillard, R. C., Riondel, A., Muller, A. F., Herrmann, W., & Baulieu, E. E. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.12.3879 · Cited by 214
Control of transcription activation by steroid hormone receptors
Gronemeyer, H. (1992) · The FASEB Journal · doi:10.1096/fasebj.6.8.1592204 · Cited by 214
McDonnell, D. P., & Goldman, M. E. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32664-9 · Cited by 211
Vegeto, E. (1993) · Molecular Endocrinology · doi:10.1210/me.7.10.1244 · Cited by 205
De Kloet, E. R., De Kock, S., Schild, V., & Veldhuis, H. D. (1988) · Neuroendocrinology · doi:10.1159/000124900 · Cited by 194
Endometrial and Pituitary Responses to the Steroidal Antiprogestin RU 486in Postmenopausal Women
GRAVANIS, A., SCHAISON, G., GEORGE, M., DE BRUX, J., SATYASWAROOP, P. G., BAULIEU, E. E., & ROBEL, P. (1985) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-60-1-156 · Cited by 189
Risk of 45,X karyotype in offspring of turner's syndrome patients. [Letters to the editor]
Otto, P. A., Kasahara, S., Nunesmaia, H. G. D. S., & Frota‐Pessoa, O. (1977) · The Lancet · Cited by 189
Groyer, A., Schweizer-Groyer, G., Cadepond, F., Mariller, M., & Baulieu, E.-E. (1987) · Nature · doi:10.1038/328624a0 · Cited by 177
Klein-Hitpass, L., Cato, A. C. B., Henderson, D., & Ryffel, G. U. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.6.1227 · Cited by 176
The glucocorticoid receptor type II complex is a target of the HIV-1 vpr gene product.
Refaeli, Y., Levy, D. N., & Weiner, D. B. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.8.3621 · Cited by 165
Regression of uterine leiomyomata to the antiprogesterone RU486: dose-response effect
Murphy, A. A., Morales, A. J., Michael Kettel, L., & Yen, S. S. C. (1995) · Fertility and Sterility · doi:10.1016/s0015-0282(16)57678-x · Cited by 164
Receptors bound to antiprogestin form abortive complexes with hormone responsive elements
Guiochon‐Mantel, A., Loosfelt, H., Ragot, T., Bailly, A., Atger, M., Misrahi, M., Perricaudet, M., & Milgröm, E. (1988) · Nature · doi:10.1038/336695a0 · Cited by 161
LIU, J. H., Garzo, G., MORRIS, S., Stuenkel, C. A., Ulmann, A., & YEN, S. S. C. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-65-6-1135 · Cited by 156
Regression of uterine leiomyomata in response to the antiprogesterone RU 486
Murphy, A. A. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.76.2.513 · Cited by 153
McDonnell, D. P., Shahbaz, M. M., Vegeto, E., & Goldman, M. E. (1994) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(94)90190-2 · Cited by 151
BARDON, S., VIGKPN, F., CHALBOS, D., & ROCHEFORT, H. (1985) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-60-4-692 · Cited by 143
Antiprogestins, a new form of endocrine therapy for human breast cancer.
Klijn, J. G. M., Jong, F. H. D., Bakker, G. H., Lamberts, S. W. J., Rodenburg, C. J., & Alexieva-Figusch, J. (1989) · PubMed · Cited by 141
Effects of the Antiprogesterone Steroid RU 486 during Midluteal Phase in Normal Women
SCHAISON, G., George, M. J., Lestrat, N., Reinberg, A., & Baulieu, E. E. (1985) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-61-3-484 · Cited by 136
A Single Amino Acid That Determines the Sensitivity of Progesterone Receptors to RU486
Benhamou, B., Garcia, T., Lerouge, T., Vergezac, A., Gofflo, D., Bigogne, C., Chambon, P., & Gronemeyer, H. (1992) · Science · doi:10.1126/science.1372753 · Cited by 135
Human glucocorticoid receptor cDNA contains sequences sufficient for receptor down-regulation.
Burnstein, K. L., Jewell, C. M., & Cidlowski, J. A. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)39112-4 · Cited by 134
Jung‐Testas, I., & Baulieu, É.-É. (1983) · Experimental Cell Research · doi:10.1016/0014-4827(83)90282-3 · Cited by 129
Effect of the antiprogesterone RU-38486 on meningioma implanted into nude mice
Olson, J. J., Beck, D. W., Schlechte, J., et al. (1987) · Journal of neurosurgery · doi:10.3171/jns.1987.66.4.0584 · Cited by 112
Wolf, J. P., Hsiu, J. G., Anderson, T. L., Ulmann, A., Baulieu, E. E., & Hodgen, G. D. (1989) · Fertility and Sterility · doi:10.1016/s0015-0282(16)53174-4 · Cited by 112
Pituitary-Adrenal Response to the Antiglucocorticoid Action of RU 486 in Cushing's Syndrome*
BERTAGNA, X. Y., BERTAGNA, C., Laudat, M. H., Husson, J., Girard, F., & LUTON, J. P. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-63-3-639 · Cited by 106
Batista, M. C., Cartledge, T. P., Zellmer, A. W., Nieman, L. K., Merriam, G. R., & Loriaux, D. L. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.74.3.1740491 · Cited by 106
van der Lely, A. J., Foeken, K., van der Mast, R. C., & Lamberts, S. W. J. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-2-143 · Cited by 105
Collins, R. L., & Hodgen, G. D. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-63-6-1270 · Cited by 104
Effects of continuous treatment with low dose mifepristone throughout one menstrual cycle
Croxatto, H. B., Salvatierra, A. M., Croxatto, H., & Fuentealba, B. (1993) · Human Reproduction · doi:10.1093/oxfordjournals.humrep.a138022 · Cited by 103
Effect of low weekly doses of mifepristone on ovarian function and endometrial development
Gemzell‐Danielsson, K., Westlund, P., JOHANNISSON, E., et al. (1996) · Human Reproduction · doi:10.1093/humrep/11.2.256 · Cited by 102
Inhibition of ovulation by low-dose mifepristone (RU 486)
Ledger, W. J., Sweeting, V., Hillier, H., et al. (1992) · Human Reproduction · doi:10.1093/oxfordjournals.humrep.a137776 · Cited by 101
Negative transcriptional regulation by nuclear receptors.
Saatcioglu, F., Claret, F. X., & Karin, M. (1994) · PubMed · Cited by 101
Progesterone and RU486: opposing effects on human sperm.
Yang, J., Serres, C., Philibert, D., Röbel, P., Baulieu, E. E., & Jouannet, P. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.2.529 · Cited by 99
The antiprogestin RU486 in advanced breast cancer: preliminary clinical trial.
Romieu, G., Maudelondé, T., Ulmann, A., Pujol, H., Grenier, J., Cavalie, G., Khalaf, S., & Rochefort, H. (1987) · PubMed · Cited by 98
RU 486 Inhibits Peripheral Effects of Glucocorticoids in Humans*
Gaillard, R. C., Poffet, D., Riondel, A. M., & Saurat, J.-H. (1985) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-61-6-1009 · Cited by 96
Effects of the antiprogesterone RU 486 in normal women
Shoupe, D., Mishell, D. R., Page, M. A., Madkour, H., Spitz, I. M., & Løbo, R. A. (1987) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(87)80236-3 · Cited by 95
Inhibition of folliculogenesis and ovulation by the antiprogesterone RU 486
Luukkainen, T., Heikinheimo, O., Haukkamaa, M., & Lähteenmäki, P. (1988) · Fertility and Sterility · doi:10.1016/s0015-0282(16)59944-0 · Cited by 95
Beck, C. A., Estes, P. A., Bona, B. J., Muro‐Cacho, C., Nordeen, S. K., & Edwards, D. P. (1993) · Endocrinology · doi:10.1210/endo.133.2.8344212 · Cited by 93
Differential steroid hormone induction of transcription from the mouse mammary tumor virus promoter
Archer, T., Lee, H. L., Cordingley, M. G., Mymryk, J. S., Fragoso, G., Berard, D. S., & Hager, G. L. (1994) · Molecular Endocrinology · doi:10.1210/mend.8.5.8058066 · Cited by 89
Weigel, N. L., Beck, C. A., Estes, P. A., Prendergast, P., Altmann, M., Christensen, K., & Edwards, D. P. (1992) · Molecular Endocrinology · doi:10.1210/me.6.10.1585 · Cited by 86
Antitumor effects of antiprogesterones on human meningioma cells in vitro and in vivo
Matsuda, Y., Kawamoto, K., Kiya, K., et al. (1994) · Journal of neurosurgery · doi:10.3171/jns.1994.80.3.0527 · Cited by 85
Progesterone receptor and the mechanism of action of progesterone antagonists
Edwards, D. P., Altmann, M., Marzo, A. M. D., Zhang, Y., Weigel, N. L., & Beck, C. A. (1995) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(95)00091-d · Cited by 85
Garzo, V. G., LIU, J. H., Ulmann, A., Baulieu, E. E., & Yen, S. S. C. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-66-3-508 · Cited by 83
The Endocrine Effects of Long-Term Treatment with Mifepristone (RU 486)
Lamberts, S. W. J., Koper, J. W., & de Jong, F. H. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-1-187 · Cited by 80
LAUE, L., LOTZE, M. T., CHROUSOS, G. P., BARNES, K., LORIAUX, D. L., & FLEISHER, T. A. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-71-6-1474 · Cited by 77
Okada, S., York, D. A., & Bray, G. A. (1992) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1992.262.6.r1106 · Cited by 72
Endometrial effects of long-term low-dose administration of RU486
Murphy, A. A., Kettel, L. M., Morales, A. J., Roberts, V. J., Parmley, T. H., & Yen, S. S. C. (1995) · Fertility and Sterility · doi:10.1016/s0015-0282(16)57478-0 · Cited by 71
Archer, T., Zaniewski, E., Moyer, M. L., & Nordeen, S. K. (1994) · Molecular Endocrinology · doi:10.1210/mend.8.9.7838148 · Cited by 68
Wolf, J. P., Sinosich, M. J., Anderson, T. L., Ulmann, A., Baulieu, E. E., & Hodgen, G. D. (1989) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(89)90084-7 · Cited by 66
Hardwick, A. J., Linton, E. A., & Rothwell, N. J. (1989) · Endocrinology · doi:10.1210/endo-124-4-1684 · Cited by 63
Lanz, R. B., & Rusconi, S. (1994) · Endocrinology · doi:10.1210/endo.135.5.7956941 · Cited by 60
Antioxidant: a new role for RU-486 and related compounds.
Parthasarathy, S., Morales, A. J., & Murphy, A. A. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117551 · Cited by 56
Beck, C. A., Zhang, Y., Weigel, N. L., & Edwards, D. P. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.2.1209 · Cited by 56
Cairns, C. A., Cairns, W. J., & Okret, S. (1993) · DNA and Cell Biology · doi:10.1089/dna.1993.12.695 · Cited by 55
Liu, W., Hillmann, A. G., & Harmon, J. M. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.2.1005 · Cited by 55
RU 486 prevents the acute effects of cortisol on glucose and leucine metabolism
Garrel, D. R., Moussalli, R., de Oliveira, A., Lesiège, D., & Larivière, F. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.2.7888013 · Cited by 53
Mechanism of action of a steroidal antiglucocorticoid in lymphoid cells.
Segnitz, B., & Gehring, U. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)39871-0 · Cited by 50
BERTAGNA, X. Y., Escourolle, H., Pinquier, J. L., Coste, J., Raux-Demay, M. C., Perles, P., Silvestre, L., LUTON, J. P., & Strauch, G. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.78.2.8106625 · Cited by 50
The two faces of a steroid antagonist: When an antagonist isn't
Nordeen, S. K., Bona, B. J., Beck, C. A., Edwards, D. P., Borror, K. C., & DeFranco, D. B. (1995) · Steroids · doi:10.1016/0039-128x(94)00001-s · Cited by 48
Papolos, D. F., Edwards, E., Marmur, R., Lachman, H. M., & Henn, F. A. (1993) · Brain Research · doi:10.1016/0006-8993(93)90042-l · Cited by 46
Kling, M. A., Demitrack, M. A., Whitfield, H. J., Kalogeras, K. T., Listwak, S. J., DeBellis, M. D., Chrousos, G. P., Gold, P. W., & Brandt, H. (2008) · Neuroendocrinology · doi:10.1159/000126474 · Cited by 45
Laue, L., Chrousos, G. P., Loriaux, D. L., Barnes, K. M., Munson, P. J., Nieman, L. K., & SCHAISON, G. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-66-2-290 · Cited by 45
Greene, K. E., Kettel, L. M., & Yen, S. S. C. (1992) · Fertility and Sterility · doi:10.1016/s0015-0282(16)55200-5 · Cited by 41
Lefèbvre, P., Danzé, P. M., Sablonnière, B., Richard, C., Formstecher, P., & Dautrevaux, M. (1988) · Biochemistry · doi:10.1021/bi00426a017 · Cited by 39
Permezel, J., Lenton, E. A., Roberts, I. M., et al. (1989) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-68-5-960 · Cited by 39
From RU 38486 towards Dissociated Antiglucocorticoid and Antiprogesterone
Philibert, D., COSTEROUSSE, G., Gaillard-Moguilewsky, M., Nédélec, L., Nique, F., Tournemine, C., & Teutsch, G. (2015) · Frontiers of hormone research · doi:10.1159/000419634 · Cited by 37
Combined effects of RU486 and tamoxifen on the growth and cell cycle phases of the MCF-7 cell line
Thomas, M., & Monet, J.-D. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.75.3.865 · Cited by 33
Differences in the binding mechanism of RU486 and progesterone to the progesterone receptor
Skafar, D. F. (1991) · Biochemistry · doi:10.1021/bi00109a003 · Cited by 32
Renoir, J., Radanyi, C., & Baulieu, É.-É. (1989) · Steroids · doi:10.1016/0039-128x(89)90142-6 · Cited by 30
Transient inhibition of RU 486 Antiglucocorticoid Action by Dexamethasone
Raux-Demay, M. C., Pierret, T., d'Yvoire, M. B., BERTAGNA, X. Y., & Girard, F. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-70-1-230 · Cited by 28
Croxatto, H. B., Salvatierra, A. M., Fuentealba, B., et al. (1995) · Human Reproduction · doi:10.1093/oxfordjournals.humrep.a136221 · Cited by 26
Clemm, D. L., Macy, B. L., Santiso‐Mere, D., & McDonnell, D. P. (1995) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(95)00095-h · Cited by 25
Pharmacological Properties of a New Selective Antiprogestagen: Org 33628
Kloosterboer, H. J., Deckers, G. H., de Gooyer, M. E., Dijkema, R., Orlemans, E. O. M., & Schoonen, W. G. E. J. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb31379.x · Cited by 24
Carbonne, B., Brennand, J. E., Maria, B., et al. (1995) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1995.tb11360.x · Cited by 22
Mizutani, T., Bhakta, A., Kloosterboer, H. J., & Moudgil, V. K. (1992) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(92)90110-5 · Cited by 21
RU 486 ADMINISTRATION IN A CHILD WITH CUSHING'S SYNDROME
Beaufrère, B., de Parscau, L., Chatelain, P., Morel, Y., Aguercif, M., & François, R. (1987) · The Lancet · doi:10.1016/s0140-6736(87)90796-3 · Cited by 20
Molecular identification of steroid analogs with dissociated antiprogestin activities
Wehle, H., Moll, J., & Cato, A. C. B. (1995) · Steroids · doi:10.1016/0039-128x(94)00067-m · Cited by 20
PERIPHERAL ANTIGLUCOCORTICOID ACTION OF RU 486 IN MAN
BERTAGNA, X. Y., Basin, C., Picard, F., Varet, B. R., BERTAGNA, C., Hucher, M., & LUTON, J. P. (1988) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1988.tb03688.x · Cited by 17
Do Receptor-Associated Nuclear Proteins Explain Earliest Steps of Steroid Hormone Function?
Baulieu, E. E., Binart, N., Cadepond, F., CATELLI, M. G., Chambraud, B., Garnier, J., Gasc, J., Schweizer-Groyer, G., Rafestin-Oblin, M. E., Radanyi, C., et al. (1989) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-5466-5_22 · Cited by 17
Kling, M. A., Whitfield, H. J., Brandt, H., Demitrack, M. A., Kalogeras, K. T., Geracioti, T. D., Perini, G., Calabrese, J. R., Chrousos, G. P., & Gold, P. W. (1989) · PubMed · Cited by 17
Effect of RU‐486 and Related Compounds on the Proliferation of Cultured Macrophages
Roberts, C. P., Parthasarathy, S., Gulati, R., Horowitz, I., & Murphy, A. A. (1995) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.1995.tb00949.x · Cited by 13
Glucocorticoid antagonists as probes to study the vascular effects of glucocorticoids.
Grünfeld, J., & Eloy, L. (1988) · PubMed · Cited by 7
van Buren, M., de Boer, P., & Koomans, H. A. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.77.4.8408463 · Cited by 6
Steroid Receptor Associated Proteins: Heat Shock Protein 90 and P59 Immunophilin
Lebeau, M., Binart, N., Cadepond, F., CATELLI, M. G., Chambraud, B., Massol, N., Radanyi, C., Redeuilh, G., Renoir, J., Sabbah, M., et al. (1994) · Birkhäuser Boston eBooks · doi:10.1007/978-1-4615-9849-7_10 · Cited by 3
Ammar, S., Allilaire, J., Lecrubier, Y., et al. (1986) · American Journal of Psychiatry · doi:10.1176/ajp.143.1.129 · Cited by 3
Cited by
An Orphan Nuclear Receptor Activated by Pregnanes Defines a Novel Steroid Signaling Pathway
Kliewer, S. A., Moore, J. T., Wade, L., Staudinger, J. L., Watson, M. A., Jones, S. A., McKee, D. D., Oliver, B. B., Willson, T. M., Zetterström, R. H., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)80900-9 · Cited by 1,539
Drugs of Abuse and Stress Trigger a Common Synaptic Adaptation in Dopamine Neurons
Saal, D., Dong, Y., Bonci, A., & Malenka, R. C. (2003) · Neuron · doi:10.1016/s0896-6273(03)00021-7 · Cited by 1,147
Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer
Kim, J. J., Kurita, T., & Bulun, S. E. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1043 · Cited by 520
Central serous chorioretinopathy: Towards an evidence-based treatment guideline
van Rijssen, T. J., van Dijk, E. H. C., Yzer, S., Ohno-Matsui, K., Keunen, J. E. E., Schlingemann, R. O., Sivaprasad, S., Querques, G., Downes, S. M., Fauser, S., et al. (2019) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2019.07.003 · Cited by 478
The Treatment of Cushing's Disease
Pivonello, R., De Leo, M., Cozzolino, A., & Colao, A. (2015) · Endocrine Reviews · doi:10.1210/er.2013-1048 · Cited by 465
Metadata
- Authors
- Cadepond, P., Ulmann, M., & Baulieu, M.
- Venue
- Annual Review of Medicine
- Publisher
- Annual Reviews
- Published
- 1997-02
- Volume
- 48
- Issue
- 1
- Pages
- 129-156
- ISSN
- 0066-4219 (ISSN-L)
- 1545-326X
- OpenAlex
- W2167223040
- Cited by
- 424
- References
- 110
- FWCI
- 2.71
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.